We conclude that expression of selected protease-activated and purinergic receptors such as F2RL1, P2RX2, P2RX3 and P2RY2 may serve for both GERD progression and GERD patients’ quality of life monitoring. Here, P2RY1 is linked to gastroesophageal reflux disease.